An international team led by researchers at CSIRO’s Australian Centre for Disease Preparedness, working with colleagues at Charles Sturt University, the Papua New Guinea Institute of Medical Research, James Cook University and La Trobe University, analyzed 13,871 female Culex mosquitoes collected across five provinces between 2019 and 2021. Using unbiased shotgun metagenomic sequencing across 86 pooled samples, the team generated approximately 1.6 billion paired-end sequencing reads, of which roughly 20 million could be assigned to viral sequences. In total, they detected 231 viral species representing 38 viral families. Of these, 120 were confirmed or probable insect-specific viruses spanning 25 viral families, and ISVs accounted for a remarkable 93.8 percent of all species-assigned viral reads.

The sheer volume of data allowed the researchers to reconstruct more than 150 complete viral genomes or genome segments, including sequences so divergent that they share less than 90 percent amino acid identity with any known reference. Approximately 40 percent of the viral reads corresponded to organisms that cannot currently be placed within any family recognized by the International Committee on Taxonomy of Viruses, underscoring how much of the mosquito virome remains formally unclassified. RNA viruses dominated the community, with the most abundant families including Partitiviridae, Birnaviridae, Rhabdoviridae and Iflaviridae.

The findings, published open access in Virology Journal, matter for reasons that go beyond cataloguing biodiversity. Insect-specific viruses are increasingly recognized as integral components of mosquito viromes that can shape virus evolution, alter vector competence and influence the ecology of arboviruses such as dengue, West Nile and Japanese encephalitis viruses. Understanding what naturally circulates in mosquito populations in a biodiversity hotspot like Papua New Guinea provides a baseline for predicting how these interactions might change, and potentially for exploiting ISVs as tools to block transmission of human pathogens.

Among the most technically significant results were the discoveries within the Partitiviridae, a family of segmented double-stranded RNA viruses better known from fungi and plants than from insects. The team identified previously unrecognized pairings between RNA-dependent RNA polymerase segments and capsid segments, an important structural insight because partitivirus genomes are split across two or more segments and reassortment between them is common. By resolving which polymerase traveled with which capsid, the researchers were able to reconstruct the complete genome architectures of Broome partiti-like virus 1 and Sonnbo virus for the first time, while also delineating additional divergent partitivirus lineages that had previously been represented only by fragments.

The birnaviruses told a biogeographic story. Sequences related to Cambodia Culex birnavirus were found in the Papua New Guinea mosquitoes, clustering within the known lineage but forming a distinct regional clade, a pattern consistent with local evolutionary divergence following geographic isolation. Such regional clustering suggests that mosquito viromes are not uniform across the Indo-Pacific, and that island geography and ecological boundaries leave detectable signatures in viral phylogenies.

Rhabdoviruses, a family that includes serious plant and vertebrate pathogens, revealed another layer of structure: host restriction. Culex tritaeniorhynchus rhabdovirus-like sequences were detected exclusively in Culex annulirostris, one of the five Culex species sampled, suggesting a tight association between particular viral lineages and particular mosquito hosts. Within the Iflaviridae, a family of positive-sense single-stranded RNA viruses related to pathogens of honeybees, several viruses were documented in Papua New Guinea for the first time. The single most abundant ISV in the entire dataset was Hubei virga-like virus 2, which formed a clade unique to Papua New Guinea, a pattern the authors interpret as evidence of local diversification.

One of the study’s more consequential observations concerns the stability of these viral communities. ISVs were detected in both blood-fed and unfed mosquitoes, indicating that they persist as permanent constituents of the mosquito virome rather than appearing transiently after blood meals. This stability is precisely what makes ISVs interesting from a biocontrol perspective: a virus that reliably colonizes mosquito populations and persists across generations could, in principle, be engineered or harnessed to interfere with the replication of human-pathogenic arboviruses, in a manner conceptually similar to the Wolbachia bacterial strategy currently deployed against dengue.

The sampling design also revealed evidence of complex infection patterns within individual insects. Multiple viral species from the same family were frequently detected within a single pooled sample, a finding consistent either with co-infection of individual mosquitoes by related viruses or with heterogeneous infections distributed among the individuals in each pool. Co-infection is particularly interesting because mixed infections create opportunities for viral recombination and reassortment, processes that can generate novel genetic combinations and potentially influence the evolutionary trajectory of entire viral lineages.

The work fills a significant geographic gap. Papua New Guinea sits within the Indo-Pacific biodiversity hotspot, a region where arbovirus transmission is a persistent public health concern and where the ancestral relatives of several major human pathogens are thought to circulate in enzootic cycles. Yet before this study, the ISV diversity of the country’s Culex populations had never been systematically surveyed. By expanding the known geographic range and genetic diversity of multiple viral groups, the research provides a reference point not only for future ecological and evolutionary studies in the region but also for global efforts to understand how mosquito-virus interactions are structured across landscapes.

Methodologically, the study demonstrates the power of unbiased metagenomic sequencing applied at scale. Rather than targeting known viruses with specific primers, the team sequenced everything in their samples and assigned reads through comparative analysis, an approach that captures divergent and entirely novel viruses that targeted methods would miss. The trade-off, as the large fraction of unclassifiable reads shows, is that such surveys routinely outpace formal taxonomy: the viruses are there, but the classification framework to describe them is still being built.

The authors, whose work was supported by the Australian Centre for International Agricultural Research with additional support from Charles Sturt University and CSIRO, emphasize that this catalog represents a baseline rather than an endpoint. With more than 150 complete genomes now available and several new lineages defined, the study lays the groundwork for investigating how these viruses are maintained in mosquito populations, how they move between vector species, and whether any of them hold promise as vehicles for suppressing the transmission of diseases that continue to burden communities across the Indo-Pacific and beyond.

For now, the mosquitoes of Papua New Guinea have revealed just a fraction of their microbial secrets, and what has emerged is a virome richer, stranger and more regionally distinctive than anyone had documented before.

Avian influenza H5N1 has wreaked havoc across agricultural sectors worldwide, forcing the mass euthanasia of over 166 million commercial poultry in the United States alone since 2022. The virus’s expansion beyond traditional avian hosts has now breached species barriers, infecting dairy cattle in an unprecedented interspecies transmission event in 2024. This unprecedented leap not just inflicted severe illness in cattle but subsequently affected approximately 70 farm workers with close contact exposure, raising alarming concerns about viral adaptation and zoonotic spillover.

The research, spearheaded by virologist Professor Eric Weaver and his team at the Nebraska Center for Virology, addresses the urgent need for a vaccine capable of preventing H5N1 infections in both poultry and mammals. Their forthcoming publication in npj Vaccines details a dual-route vaccination method, meticulously designed to elicit comprehensive immune defenses within the systemic circulation and the mucosal surfaces of the respiratory tract. This approach embodies a significant paradigm shift, aiming to block viral replication and transmission simultaneously.

The vaccine’s mechanism involves administering a prime immunization via intramuscular injection and a subsequent booster through intranasal delivery. This bifurcated strategy stimulates the generation of systemic antibodies that neutralize the virus throughout the body, while the mucosal immunity induced intranasally forms a frontline barrier in the respiratory tract to inhibit viral shedding and horizontal spread. Such an integrated immunological approach is critical given the respiratory tropism of influenza viruses and their propensity for rapid transmission among livestock.

In-depth experimental assessments in mice demonstrated complete protection against lethal doses from multiple H5N1 viral strains, affirming the broad cross-protective capabilities of the vaccine candidates. Following these promising murine data, the research pivoted towards dairy calves, where the challenges of large-animal vaccine efficacy are significantly pronounced due to physiological and immunological complexities. Impressively, neonatal calves vaccinated at one week of age exhibited potent immune responses and were shielded from severe disease following viral challenge.

The urgency of this development stems from the absence of currently licensed vaccines targeting H5N1 in cattle, despite the newfound vulnerability of this species. Professor Weaver notes that although his laboratory had investigated similar vaccine platforms over a decade ago with avian models, the unprecedented outbreak in cattle galvanized renewed focus. “When the outbreak began, my hope was this would cycle through and subside in dairy cattle, but the persistence and worsening situation necessitated immediate action,” Weaver reflects.

In collaboration with expert animal care teams, the vaccine protocol incorporated a booster shot at four weeks post-primary immunization, which significantly enhanced and sustained immunological memory. This dosing regimen is strategically aligned with immunological principles that promote T-cell and B-cell maturation, ultimately leading to long-lasting protective immunity. Importantly, the dual-route administration ensures mucosal tissues receive adequate stimulation, which is often a bottleneck in conventional vaccine platforms.

Beyond the immediate goal of protecting animal health, this vaccine innovation bears considerable economic significance. The H5N1 outbreak has inflicted substantial financial losses on producers due to mortality and culling measures. Containment of the virus at the livestock level could dramatically reduce these impacts while also mitigating public health risks associated with viral evolution and spillover into humans, particularly those working in close proximity to infected animals.

Professor Weaver envisions a future where this vaccination platform could be adapted as a multispecies vaccine, offering dual benefits for both animals and humans. The intricate interplay between animal reservoirs and human susceptibility underlines the necessity of One Health approaches to infectious disease management. “Our aim is to develop a vaccine not only for the farm animals but also for the farmers themselves, providing a comprehensive shield against H5N1,” Weaver emphasizes.

In an era characterized by increasing zoonotic threats, this vaccine development stands as a testament to the critical need for cross-disciplinary research integrating virology, immunology, and veterinary medicine. It also highlights the significance of rapid translational science, wherein pre-existing foundational research can be swiftly pivoted to address emergent infectious threats, thereby protecting both agriculture and public health sectors.

Further research efforts are underway to secure funding and establish partnerships aimed at advancing the vaccine through rigorous clinical and field trials. Success in these endeavors could ultimately lead to regulatory approval and widespread deployment, transforming the landscape of influenza control in livestock and preventing future outbreaks that jeopardize global food security and human health.

The H5N1 avian influenza episode marks a historic departure from traditional host boundaries, emphasizing that influenza A viruses, once not considered a threat to bovine health, now require dedicated interventions. As these viruses continue their evolutionary trajectories, proactive vaccine development strategies such as this are paramount to preclude the establishment of new reservoirs and protect populations at the interface of animal-human transmission.

Subject of Research: Animals
Article Title: Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models
News Publication Date: 21-Apr-2026
Web References: 10.1038/s41541-026-01460-6
References: Available in npj Vaccines, DOI 10.1038/s41541-026-01460-6
Image Credits: Not provided

Keywords: H5N1, avian influenza, vaccine development, systemic immunity, mucosal immunity, intramuscular vaccination, intranasal vaccination, bovine influenza, zoonotic diseases, One Health, viral cross-species transmission, livestock protection